Smith Sawyer Facebook ad: “My doctor said i'd regret it”

About this ad

Meta Ad Library ID

1505108161628858

Platforms

Facebook, Instagram, Audience Network, Messenger and Threads

Relaunches

0

How we count

Ad text

My father lost feeling in his feet at my son's birthday party. He was sitting in the backyard in one of those folding chairs. My son ran over to show him something (a toy, I forget what) and bumped into his leg on the way past. My father reached down to rub his shin and his hand just stayed there. Pressing. Not feeling anything back. He looked up at me. Something passed across his face that I didn't understand at the time. He was 62. Type 2 diabetic for eleven years. I was 31 that day. Now I'm 43. And three months ago I sat on the edge of my bed at midnight, pressing my thumb into the top of my left foot. Trying to feel my own hand. I need to tell you about my father first. Because nothing I found makes sense without knowing what I watched happen to him. The tingling started at his ankles, which is how it always starts. Like something crawling just under the skin. He mentioned it at a routine visit. His doctor said it was peripheral neuropathy, common with long-term diabetes, told him to keep his blood sugar controlled and come back if it worsened. He controlled his blood sugar. The tingling spread. Within two years it had moved past his knees. At night it stopped being tingling and became electricity. Sharp, zapping sensations that woke him up at 1, 2, 3 in the morning. My mother would hear him shuffling around the kitchen in the dark. Not looking for anything. Just trying to walk it out. Then came the burning. He described it to me one evening when he'd had enough to drink to say it plainly. Walking to the bathroom at night felt like crossing hot coals barefoot. He'd started wearing two pairs of socks to bed. Then three. He put a folded towel under his feet because even the sheet weight against his ankles was too much. I used to call him Sunday mornings. He stopped picking up around the time he went on gabapentin. My mother said he was tired. When I drove over, I saw the dark circles. The way he lowered himself into his chair like it required calculation. The flinch when the dog bumped against his legs. He wasn't tired. He was a man who hadn't slept a full night in two years. They put him on three hundred milligrams. Then six hundred. Then nine hundred, because the lower doses weren't enough. I watched my father become someone I didn't fully recognize across those months. Not in the way pain changes people. Something quieter than that. The man I grew up with could tell you the batting average of every player on the 1984 Cubs roster. He argued about local politics at dinner with dates and sources. He fixed his own car, built his own shelves, never asked anyone for help with anything. That man started going dim. He sat in his chair more. Got confused about small things. Gained weight without changing what he ate. He told me once, quietly, that he felt like he was watching his own life from slightly too far away. Present, but not quite inside it. "The burning is a little less," he said. "But I don't feel like myself." That sentence never left me. His neurologist called it well-managed. My father called it existing. The burning didn't stop. The gabapentin filed the sharpest edges off the worst spikes while trading them for fog. He was paying for less fire with more cotton. And both of them were taking him away from his own life. He stopped driving at 67. He couldn't trust the feeling in his feet on the pedals. He stopped going to the hardware store on Saturday mornings, which he had done every single Saturday for thirty years. He stopped walking the neighborhood after dinner with my mother, something they'd done since I was in grade school. Not because he fell. Not because anything dramatic happened. Because he couldn't trust the ground. That part never gets explained. Neuropathy doesn't just cause pain. It removes your ability to trust your own body. Every step becomes a calculation. Every surface becomes a question. Is the ground where I think it is. Did I just catch myself or did I imagine that. How many more steps to the chair. He aged a decade in three years. My mother quietly stopped inviting him to outdoor events. School plays, birthday parties, soccer games in the park. Any kind of uneven surface. She stopped asking. He stopped going. The grandkids stopped expecting to see him there. He died at 74, which isn't young. But my father at 65 and my father at 74 were not the same man. The last nine years were a slow giving-up of everything that made his life feel like his. Gabapentin managed the chart. His life went anyway. Three months ago my doctor tested my feet at a routine physical. Cold sensation. Warm sensation. Sharp pressure at the ball of my foot. Vibration with a tuning fork at the base of my big toe on both feet. She paused before moving to the next test. "Have you been noticing any tingling? Anything unusual in your feet or lower legs?" I had. For about seven months. I'd been calling it fatigue, sitting wrong, tired muscles. Calling it everything except what it was. "Your nerve response is reduced at several sites," she said. "Given your diabetes history, this is consistent with early peripheral neuropathy. We're going to want to monitor this and discuss management." Management. I knew exactly what management meant. I had watched twelve years of management. I drove home with both hands tight on the wheel. My son is thirteen. He plays soccer on Saturday mornings and has been asking me to coach his spring team for two years. I keep telling him next season. I thought about my father missing my son's school plays because the steps were uneven. I thought about not being able to trust wet grass. I thought about watching my own life from slightly too far away. I was not going to let that happen. That night after my family went to sleep I sat at the kitchen table with my laptop and started reading. Not looking for pain relief. Looking for what was actually causing the damage. Everything came back to the same mechanism. Diabetes keeps blood sugar elevated. That elevated blood sugar slowly destroys the tiny blood vessels that feed peripheral nerves. The vessels narrow and restrict flow. The nerves begin starving for oxygen and nutrients. And as nerve cells start to die, they release unstable molecules called free radicals that accelerate the damage to everything around them. It isn't only that the nerves stop getting fed. The dying process itself makes everything worse. I read about gabapentin specifically. What it was actually doing. It works in the brain, not the nerve. It reduces the brain's capacity to process the incoming pain signal. Which is why my father's burning was "a little less" but his cognition went quiet at the same time. The drug does nothing to interrupt the damage progressing underneath. The blood vessels keep narrowing. The free radicals keep accumulating. The fibers keep dying. Gabapentin turns down the alarm while the fire spreads beneath it. If free radicals are what's destroying the nerve tissue, what actually neutralizes free radicals? Antioxidants. That is their specific function. But here was the problem I kept finding. Nerve cells are wrapped in a fatty outer membrane. Most antioxidants are water-soluble. They work in the fluid between cells but cannot cross a fat barrier. They are doing a partial job. Working on the outside of the nerve cell. Unable to reach the interior where the free radicals are doing the most damage. I found one compound mentioned across multiple independent studies on diabetic nerve damage. R-Alpha Lipoic Acid. I'd never encountered it before. I almost skipped past it. What stopped me was a single characteristic the papers kept returning to. R-ALA is both water-soluble and fat-soluble simultaneously. That is almost unique among antioxidant molecules. It can pass through the fatty outer membrane of a nerve cell and work inside the watery interior at the same time. It neutralizes free radicals in both zones at once. Inside and outside the nerve cell. Full coverage. No other common antioxidant does that. The research went back to the 1960s in Germany, where R-ALA had been used for diabetic nerve conditions for decades. Clinical trials with measurable outcomes. Nerve conduction velocity. Burning and tingling scores. Numbness ratings. And the papers kept specifying the R form, the naturally occurring version, not the synthetic racemic blend found in most supplements. That detail mattered, I found out later. There's an L form and an R form of Alpha Lipoic Acid. The body produces the R form. It's the one the cellular machinery recognizes. Most supplement manufacturers make a synthetic blend of both forms because it's cheaper to produce. The L form has limited biological activity. It dilutes the effective dose and cuts the cost. Most ALA products on the market are giving you roughly half the active compound. I had a narrow window. My doctor had said it plainly. Early neuropathy is when intervention matters most. Once nerve fibers are lost, they don't come back. What remained could still be protected. What was gone was gone. I ordered the first R-ALA product I found that night. Thousands of reviews. High rating. "Alpha lipoic acid" on the label. Took it for eight weeks. The tingling at night didn't change. I went back to the research. Started reading more carefully. Looking at what separated studies that showed real nerve protection from studies that didn't. Three things came up repeatedly. R form only, not a racemic blend. Delivery method: ALA is poorly absorbed from dry powder capsules, and fat-soluble compounds need a fat carrier to cross the gut wall and reach peripheral tissue. And dose: the clinical research used 600mg of active R-ALA, not the 100 to 200mg in most retail products. The product I'd been taking was a powder blend in a hard capsule. Wrong form, wrong dose, no fat carrier. I wasn't taking the wrong thing. I was taking a version of it that couldn't get where it needed to go. I started looking specifically. R-ALA only. 600mg. Softgel format with a fat base. Third-party tested so there was a certificate of analysis I could actually read. I wasn't finding it easily. Most products didn't list their form. Most didn't specify. I spent a few nights going through labels on manufacturer sites. I had a follow-up appointment with my doctor's office that week. There's a small health food shop two blocks from the medical building, one of those places that's been there for thirty years, the kind with handwritten signs and someone behind the counter who actually reads the literature. I went in before the appointment and described what I was looking for. R-ALA specifically. Softgel. Coconut oil or similar fat base. Six hundred milligrams. The woman behind the counter, who'd been there for years and knew the inventory by memory, looked at me for a moment. "You've done your reading," she said. She told me most of what's on the shelf is racemic blend in a dry capsule. She'd stocked a few things over the years that met the actual clinical criteria, but they came and went. Then she mentioned she'd recently started pointing people toward a brand she'd been looking into. She wrote the name on a piece of register paper and slid it across the counter. Vesterial. R-Alpha Lipoic Acid softgels. The R form only, 600mg, suspended in coconut oil. A pouch, not a bottle. She said she'd looked at their formulation specifically because of the delivery: the coconut oil base is what carries fat-soluble compounds through the gut wall and into peripheral tissue. It isn't a filler. It's the transport mechanism. I looked it up on my phone before I left the shop. The coconut oil mattered for a specific reason I hadn't fully understood until I read it again. Nerve cell membranes are fatty. R-ALA has to reach nerve tissue, not just circulate. The fat base moves it to the right destination. Water-based delivery, or dry powder with no carrier, loses a significant portion of the active compound before it reaches peripheral nerves. I also noticed something else I had wondered about before. R-ALA isn't patentable. It's a naturally occurring molecule. No pharmaceutical company owns it. There's no revenue model for educating neurologists or printing clinical guidelines around it. No sales representatives walking into doctors' offices with literature on it. No advertising budget. Gabapentin is patented. There's a whole industry built around managing the alarm. There's nothing built around telling a diabetic patient that a specific antioxidant can reach both zones of the nerve cell and neutralize the free radicals destroying it. No one told my father. No one told me until I went looking. I ordered Vesterial that afternoon. Week one. I wasn't tracking anything dramatic. The tingling at night was still there. Feet still restless against the sheets around 11 PM. But around day five I slept through until 4 AM without waking to reposition my legs. I noted it. Wasn't sure if it meant anything. Week two. Slept through twice. The background hum in my feet during the evenings, that low-level awareness I'd been managing around, was slightly quieter. Not absent. Quieter. I started tracking it on a scale from one to ten each evening. Week one average had been around a six. Week two was tracking closer to four. Week three. My wife noticed before I said anything. We were sitting watching television and she looked over at me. "You seem easier," she said. I hadn't been fidgeting. I'd been sitting still for forty minutes without realizing it. That was new. I told her what I'd been taking. She asked how it worked. I explained the dual solubility. The R form. The fat base getting it to nerve tissue. She listened and was quiet for a moment. "Your dad never had any of that explained to him." No. He didn't. Week four. Evening tingling tracking consistently at three to four. Sleeping most nights through to 5 or 5:30 AM. Started walking the neighborhood after dinner the way I used to before the symptoms started. Did it three evenings that week without thinking about my feet once. Week six. Something happened that I wasn't tracking but my wife was. She said I'd started touching her hand again when we passed in the kitchen. She said I'd stopped doing that for about a year without either of us naming it. I hadn't realized. Week eight. I went back to my doctor's office. She ran the same tests. Cold, warm, sharp pressure, vibration with the tuning fork. She was quiet for a moment after the vibration test on my left foot. "This site tested better than your last visit." She moved to the right foot. Ran the sequence. "Both sites." She looked up. "What did you change?" I told her. R-ALA, the R form only. 600mg. Softgel in coconut oil. The dual solubility getting it inside the nerve cell membrane. The free radical neutralization in both zones simultaneously. She pulled something up on her computer and read without speaking for about a minute. "There is a reasonably strong evidence base for this," she said, more to herself than to me. "Particularly the German trials. I should be raising this with patients earlier." She closed the laptop. "Come back in three months. I want to see where this tracks." Come back in three months. Not let's talk about next medication steps. Not this is what well-managed looks like. Come back. Two weeks after that appointment I showed up to my son's Saturday soccer practice. Not to watch. To coach. First time on that field. Wet grass, uneven ground along the sideline where the drainage isn't great. I ran the warmup drill with them, moved the cones, demonstrated the first touch sequence. An hour and fifteen minutes. I didn't think about the ground once. After practice my son ran over still breathing hard. "Dad, can you do all the games this season?" I told him I wasn't missing a single one. I thought about my father at 68. Still in his chair. Watching his grandkids' games through a window or not at all because the parking lot surface wasn't reliable. Watching his own life from a few feet too far away. He didn't have what I found. Nobody explained that the damage was being driven by free radicals that one specific molecule could reach in both zones of the nerve cell simultaneously. Nobody explained that gabapentin was answering the alarm, not the fire underneath it. Nobody explained it because there was no money in explaining it. You're reading this because you're somewhere in that same story. Maybe the tingling started at the ankle and you've been calling it something else. Maybe it's moved past the knee. Maybe the nights are already worse than the days, and you know what the sheet weight feels like. Maybe you've been prescribed gabapentin, or your neurologist has brought it up, and you've either already felt the fog your doctor didn't mention or you're watching someone else live inside it and you don't want that. Maybe you've watched a parent lose twelve years to this, an inch at a time, and you recognize the direction you're heading in. There are two paths from where you're standing right now. The first path is management. Gabapentin for the signal, dose increases when it stops being enough, a life that gets smaller around the edges as the nerve damage continues underneath the quieter alarm. Your chart looks managed. The fibers keep dying. You stop driving. You stop trusting the ground. The second path is what I found after eight weeks of searching. Addressing the free radicals directly, with the one antioxidant that reaches both sides of the nerve cell membrane simultaneously, in the form and delivery the clinical research actually used. I chose the second path. Here's what makes Vesterial different from the ALA products I tried first and every racemic blend capsule on the market. Only the R form. The naturally occurring version the body recognizes. Not a synthetic blend where half the dose has limited biological activity. 600mg per serving. The dose that corresponds to what clinical research used, not a fraction of it. Softgel suspended in coconut oil. A fat base that carries the compound through the gut wall and into the fatty membrane of nerve cells where the free radicals are doing the damage. Not a dry powder capsule that loses significant absorption before reaching peripheral tissue. Both water and fat soluble. Meaning it works inside and outside the nerve cell simultaneously. Protecting and working toward repair in both zones at once. No other single antioxidant does that. 120 softgels per pouch. Roughly a month's supply. There's a 60-day money back guarantee. No questions, full refund if you don't feel a difference. What you're risking is nothing. What you're potentially protecting is everything that comes after this. I can't give my father those nine years back. I can't give him Saturday mornings at the hardware store. I can't give him the evening walks with my mother. I can't give him the feeling of ground he could trust. But I can stand on that wet grass with my son. I can be at every game. I can be the father who's on the field, not the one who stayed in the car. I'm sharing the link below for people like me. People who've been told management is the only option. People watching a parent disappear a little at a time and seeing themselves in it. You don't have to accept the first path. https://vesterial.com/products/r-alpha-lipoic-acid-softgel-extracts P.S. The first thing that changed was sleep. Around day five of week one. The evening tracking I was doing went from a six to a four by the end of week two. Week three my wife noticed I'd stopped fidgeting before I did. Week eight my doctor tested both feet and both sites came back measurably better than my previous visit. She said she should be raising R-ALA with diabetic patients earlier. Your timeline will be different. But you won't know what's possible without trying something that actually addresses the mechanism. P.P.S. Gabapentin reduces the brain's perception of the signal. It does not slow or stop the nerve damage continuing underneath. Every day without addressing the free radical accumulation is another day of nerve fibers that cannot come back. My father had nine years of that. The window to protect what remains is the one you have right now, not the one after the next decline. The 60-day guarantee means you risk nothing by starting today instead of waiting. P.P.P.S. The woman at the health food shop said most people come in having tried racemic blend powder capsules and felt nothing, and they assume R-ALA just doesn't work for them. It wasn't the compound that failed. It was the form, the dose, and the delivery. Wrong form. No fat carrier. A fraction of the clinical dose. Vesterial is what the research actually describes. There's a difference between trying ALA and trying the thing the studies used.

Where the ad sends people

vesterial.com

My doctor said i'd regret it

Vesterial